{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:10:41Z","timestamp":1770354641393,"version":"3.49.0"},"reference-count":44,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"14","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Recent studies report that cerebellar glioblastoma (GBM) is categorized into the RTK1 methylation class. GBM pediatric RTK (pedRTK) subtypes are distinct from those of adult GBM. We present a unique adult case of cerebellar GBM classified into the pedRTK subtype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>Magnetic resonance imaging revealed a homogeneous enhancing lesion in the right cerebellum in a 56-year-old woman presenting with ataxia and dizziness. Arterial spin labeling and angiographic findings and the intraoperative orange-colored tumor appearance were reminiscent of hemangioblastoma. She showed an atypical presentation in terms of high glucose metabolism. The histological diagnosis was high-grade glioma with differentiation similar to central nervous system neuroblastoma. The methylation class was GBM pedRTK1. Consistent with this classification, immunoexpression was positive for SOX10 and negative for ANKRD55. She underwent craniospinal radiotherapy (23.4 Gy) with a boost to the tumor bed (total 55.8 Gy). Twelve courses of temozolomide therapy were administered. There was no recurrence 18 months after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>Radiological and intraoperative findings, such as hemangioblastoma and high glucose metabolism, were notable characteristics in the present case. Both glial and neuronal differentiation and SOX10 immunoexpression were presenting pathological features. Similar cerebellar GBMs might form a previously unestablished subtype. Establishing effective molecular diagnoses is important.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case2260","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:08:50Z","timestamp":1649041730000},"source":"Crossref","is-referenced-by-count":0,"title":["Adult cerebellar glioblastoma categorized into a pediatric methylation class with a unique radiological and histological appearance: illustrative case"],"prefix":"10.3171","volume":"3","author":[{"given":"Takahiro","family":"Ono","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Hinz","sequence":"additional","affiliation":[{"name":"Department for Neuropathology and CCU Neuropathology, University of Heidelberg and DKFZ, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nanjo","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Akita University Hospital, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[{"name":"Department for Neuropathology and CCU Neuropathology, University of Heidelberg and DKFZ, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"6","key":"b1","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00401-017-1771-1","article-title":"Distinct molecular profile of diffuse cerebellar gliomas","volume":"134","author":"Nomura M","year":"2017","unstructured":"Nomura M, Mukasa A, Nagae G,  Distinct molecular profile of diffuse cerebellar gliomas. Acta Neuropathol. 2017;134(6):941\u2013956.10.1007\/s00401-017-1771-1"},{"issue":"3","key":"b2","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-017-1710-1","article-title":"H3-\/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers","volume":"134","author":"Korshunov A","year":"2017","unstructured":"Korshunov A, Schrimpf D, Ryzhova M,  H3-\/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol. 2017;134(3):507\u2013516.10.1007\/s00401-017-1710-1"},{"issue":"7697","key":"b3","series-title":"Nature","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper D","year":"2018","unstructured":"Capper D, Jones DTW, Sill M,  DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u2013474.10.1038\/nature26000"},{"issue":"6","key":"b4","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","article-title":"Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets","volume":"131","author":"Sahm F","year":"2016","unstructured":"Sahm F, Schrimpf D, Jones DT,  Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol. 2016;131(6):903\u2013910.10.1007\/s00401-015-1519-8"},{"issue":"2","key":"b5","series-title":"Cell","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan CW","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A,  The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462\u2013477.10.1016\/j.cell.2013.09.034"},{"issue":"1","key":"b6","series-title":"Acta Neuropathol Commun","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-021-01118-5","article-title":"Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation","volume":"9","author":"Korshunov A","year":"2021","unstructured":"Korshunov A, Okonechnikov K, Schmitt-Hoffner F,  Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation. Acta Neuropathol Commun. 2021;9(1):20.10.1186\/s40478-021-01118-5"},{"issue":"4","key":"b7","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm D","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V,  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012;22(4):425\u2013437.10.1016\/j.ccr.2012.08.024"},{"issue":"5","key":"b8","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational landscape and clonal architecture in grade II and III gliomas","volume":"47","author":"Suzuki H","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K,  Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015;47(5): 458\u2013468.10.1038\/ng.3273"},{"issue":"10","key":"b9","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar A","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D,  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813\u2013820.10.1016\/S1470-2045(06)70867-1"},{"issue":"25","key":"b10","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer RJ","year":"2006","unstructured":"Packer RJ, Gajjar A, Vezina G,  Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24(25):4202\u20134208.10.1200\/JCO.2006.06.4980"},{"key":"b11","series-title":"World Health Organization classification of tumours","year":"2021","unstructured":"Louis DOH, Wiestler OD, Cavenee WK, eds. World Health Organization classification of tumours. 5th ed. Lyon, France: IARC Press; 2021."},{"key":"b12","series-title":"Neurol Med Chir (Tokyo)","first-page":"9","article-title":"Brain Tumor Registry of Japan (2005-2008)","volume":"57","year":"2017","unstructured":"Anonymous. Brain Tumor Registry of Japan (2005-2008). Neurol Med Chir (Tokyo). 2017;57(Suppl 1):9\u2013102."},{"key":"b13","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1016\/j.wneu.2017.11.054","article-title":"Usefulness of 18F-fluorodeoxyglucose-positron emission tomography in comparison with methionine-positron emission tomography in differentiating solid hemangioblastoma from adult cerebellar tumors","volume":"110","author":"Takahashi Y","year":"2018","unstructured":"Takahashi Y, Nishio A, Yamamoto D, Kamada H, Hashimoto N. Usefulness of 18F-fluorodeoxyglucose-positron emission tomography in comparison with methionine-positron emission tomography in differentiating solid hemangioblastoma from adult cerebellar tumors. World Neurosurg. 2018;110:e648\u2013e652.10.1016\/j.wneu.2017.11.054"},{"issue":"1","key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3171\/jns.1984.60.1.0094","article-title":"Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford","volume":"60","author":"Helle TL","year":"1984","unstructured":"Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg. 1984;60(1):94\u2013103.10.3171\/jns.1984.60.1.0094"},{"issue":"6","key":"b15","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2176\/nmc.oa.2020-0375","article-title":"Differentiating between primary central nervous system lymphoma and glioblastoma: the diagnostic value of combining 18F-fluorodeoxyglucose positron emission tomography with arterial spin labeling","volume":"61","author":"Hatakeyama J","year":"2021","unstructured":"Hatakeyama J, Ono T, Takahashi M, Oda M, Shimizu H. Differentiating between primary central nervous system lymphoma and glioblastoma: the diagnostic value of combining 18F-fluorodeoxyglucose positron emission tomography with arterial spin labeling. Neurol Med Chir (Tokyo). 2021;61(6):367\u2013375.10.2176\/nmc.oa.2020-0375"},{"issue":"1","key":"b16","series-title":"Nat Commun","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/s41467-020-20225-w","article-title":"Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype","volume":"11","author":"Wu Y","year":"2020","unstructured":"Wu Y, Fletcher M, Gu Z,  Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype. Nat Commun. 2020;11(1):6434.10.1038\/s41467-020-20225-w"},{"issue":"20","key":"b17","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/sj.onc.1206442","article-title":"The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia","volume":"22","author":"Mollaaghababa R","year":"2003","unstructured":"Mollaaghababa R, Pavan WJ. The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene. 2003;22(20): 3024\u20133034.10.1038\/sj.onc.1206442"},{"issue":"8","key":"b18","series-title":"BioEssays","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/bies.20445","article-title":"Sorting out Sox10 functions in neural crest development","volume":"28","author":"Kelsh RN","year":"2006","unstructured":"Kelsh RN. Sorting out Sox10 functions in neural crest development. BioEssays. 2006;28(8):788\u2013798.10.1002\/bies.20445"},{"issue":"6","key":"b19","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/PAS.0000000000000398","article-title":"Sox10\u2014a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors","volume":"39","author":"Miettinen M","year":"2015","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M,  Sox10\u2014a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol. 2015;39(6):826\u2013835.10.1097\/PAS.0000000000000398"},{"issue":"2","key":"b20","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-006-9180-7","article-title":"Expression of SOX9 and SOX10 in central neuroepithelial tumor","volume":"80","author":"Kordes U","year":"2006","unstructured":"Kordes U, Hagel C. Expression of SOX9 and SOX10 in central neuroepithelial tumor. J Neurooncol. 2006;80(2):151\u2013155.10.1007\/s11060-006-9180-7"},{"issue":"3","key":"b21","series-title":"Brain Tumor Pathol","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10014-020-00370-2","article-title":"Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report","volume":"37","author":"Furuta T","year":"2020","unstructured":"Furuta T, Moritsubo M, Muta H,  Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report. Brain Tumor Pathol. 2020;37(3): 100\u2013104.10.1007\/s10014-020-00370-2"},{"issue":"5","key":"b22","series-title":"Cell","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs","volume":"164","author":"Sturm D","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH,  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016;164(5):1060\u20131072.10.1016\/j.cell.2016.01.015"},{"issue":"6","key":"b1","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00401-017-1771-1","article-title":"Distinct molecular profile of diffuse cerebellar gliomas","volume":"134","author":"Nomura M","year":"2017","unstructured":"Nomura M, Mukasa A, Nagae G,  Distinct molecular profile of diffuse cerebellar gliomas. Acta Neuropathol. 2017;134(6):941\u2013956.10.1007\/s00401-017-1771-1"},{"issue":"3","key":"b2","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-017-1710-1","article-title":"H3-\/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers","volume":"134","author":"Korshunov A","year":"2017","unstructured":"Korshunov A, Schrimpf D, Ryzhova M,  H3-\/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol. 2017;134(3):507\u2013516.10.1007\/s00401-017-1710-1"},{"issue":"7697","key":"b3","series-title":"Nature","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper D","year":"2018","unstructured":"Capper D, Jones DTW, Sill M,  DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u2013474.10.1038\/nature26000"},{"issue":"6","key":"b4","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","article-title":"Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets","volume":"131","author":"Sahm F","year":"2016","unstructured":"Sahm F, Schrimpf D, Jones DT,  Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol. 2016;131(6):903\u2013910.10.1007\/s00401-015-1519-8"},{"issue":"2","key":"b5","series-title":"Cell","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan CW","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A,  The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462\u2013477.10.1016\/j.cell.2013.09.034"},{"issue":"1","key":"b6","series-title":"Acta Neuropathol Commun","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-021-01118-5","article-title":"Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation","volume":"9","author":"Korshunov A","year":"2021","unstructured":"Korshunov A, Okonechnikov K, Schmitt-Hoffner F,  Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation. Acta Neuropathol Commun. 2021;9(1):20.10.1186\/s40478-021-01118-5"},{"issue":"4","key":"b7","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm D","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V,  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012;22(4):425\u2013437.10.1016\/j.ccr.2012.08.024"},{"issue":"5","key":"b8","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational landscape and clonal architecture in grade II and III gliomas","volume":"47","author":"Suzuki H","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K,  Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015;47(5): 458\u2013468.10.1038\/ng.3273"},{"issue":"10","key":"b9","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar A","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D,  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813\u2013820.10.1016\/S1470-2045(06)70867-1"},{"issue":"25","key":"b10","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer RJ","year":"2006","unstructured":"Packer RJ, Gajjar A, Vezina G,  Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24(25):4202\u20134208.10.1200\/JCO.2006.06.4980"},{"key":"b11","series-title":"World Health Organization classification of tumours","year":"2021","unstructured":"Louis DOH, Wiestler OD, Cavenee WK, eds. World Health Organization classification of tumours. 5th ed. Lyon, France: IARC Press; 2021."},{"key":"b12","series-title":"Neurol Med Chir (Tokyo)","first-page":"9","article-title":"Brain Tumor Registry of Japan (2005-2008)","volume":"57","year":"2017","unstructured":"Anonymous. Brain Tumor Registry of Japan (2005-2008). Neurol Med Chir (Tokyo). 2017;57(Suppl 1):9\u2013102."},{"key":"b13","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1016\/j.wneu.2017.11.054","article-title":"Usefulness of 18F-fluorodeoxyglucose-positron emission tomography in comparison with methionine-positron emission tomography in differentiating solid hemangioblastoma from adult cerebellar tumors","volume":"110","author":"Takahashi Y","year":"2018","unstructured":"Takahashi Y, Nishio A, Yamamoto D, Kamada H, Hashimoto N. Usefulness of 18F-fluorodeoxyglucose-positron emission tomography in comparison with methionine-positron emission tomography in differentiating solid hemangioblastoma from adult cerebellar tumors. World Neurosurg. 2018;110:e648\u2013e652.10.1016\/j.wneu.2017.11.054"},{"issue":"1","key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3171\/jns.1984.60.1.0094","article-title":"Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford","volume":"60","author":"Helle TL","year":"1984","unstructured":"Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg. 1984;60(1):94\u2013103.10.3171\/jns.1984.60.1.0094"},{"issue":"6","key":"b15","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2176\/nmc.oa.2020-0375","article-title":"Differentiating between primary central nervous system lymphoma and glioblastoma: the diagnostic value of combining 18F-fluorodeoxyglucose positron emission tomography with arterial spin labeling","volume":"61","author":"Hatakeyama J","year":"2021","unstructured":"Hatakeyama J, Ono T, Takahashi M, Oda M, Shimizu H. Differentiating between primary central nervous system lymphoma and glioblastoma: the diagnostic value of combining 18F-fluorodeoxyglucose positron emission tomography with arterial spin labeling. Neurol Med Chir (Tokyo). 2021;61(6):367\u2013375.10.2176\/nmc.oa.2020-0375"},{"issue":"1","key":"b16","series-title":"Nat Commun","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/s41467-020-20225-w","article-title":"Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype","volume":"11","author":"Wu Y","year":"2020","unstructured":"Wu Y, Fletcher M, Gu Z,  Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype. Nat Commun. 2020;11(1):6434.10.1038\/s41467-020-20225-w"},{"issue":"20","key":"b17","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/sj.onc.1206442","article-title":"The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia","volume":"22","author":"Mollaaghababa R","year":"2003","unstructured":"Mollaaghababa R, Pavan WJ. The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene. 2003;22(20): 3024\u20133034.10.1038\/sj.onc.1206442"},{"issue":"8","key":"b18","series-title":"BioEssays","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/bies.20445","article-title":"Sorting out Sox10 functions in neural crest development","volume":"28","author":"Kelsh RN","year":"2006","unstructured":"Kelsh RN. Sorting out Sox10 functions in neural crest development. BioEssays. 2006;28(8):788\u2013798.10.1002\/bies.20445"},{"issue":"6","key":"b19","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/PAS.0000000000000398","article-title":"Sox10\u2014a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors","volume":"39","author":"Miettinen M","year":"2015","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M,  Sox10\u2014a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol. 2015;39(6):826\u2013835.10.1097\/PAS.0000000000000398"},{"issue":"2","key":"b20","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-006-9180-7","article-title":"Expression of SOX9 and SOX10 in central neuroepithelial tumor","volume":"80","author":"Kordes U","year":"2006","unstructured":"Kordes U, Hagel C. Expression of SOX9 and SOX10 in central neuroepithelial tumor. J Neurooncol. 2006;80(2):151\u2013155.10.1007\/s11060-006-9180-7"},{"issue":"3","key":"b21","series-title":"Brain Tumor Pathol","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10014-020-00370-2","article-title":"Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report","volume":"37","author":"Furuta T","year":"2020","unstructured":"Furuta T, Moritsubo M, Muta H,  Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report. Brain Tumor Pathol. 2020;37(3): 100\u2013104.10.1007\/s10014-020-00370-2"},{"issue":"5","key":"b22","series-title":"Cell","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs","volume":"164","author":"Sturm D","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH,  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016;164(5):1060\u20131072.10.1016\/j.cell.2016.01.015"}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/3\/14\/article-CASE2260.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/3\/14\/article-CASE2260.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/3\/14\/article-CASE2260.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:43:35Z","timestamp":1770302615000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/3\/14\/article-CASE2260.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":44,"journal-issue":{"issue":"14"},"URL":"https:\/\/doi.org\/10.3171\/case2260","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]}}}